MX2017007130A - Metodos para el tratamiento de la desregulacion del mejorador de la cadena ligera kappa del factor nuclear de las celulas b activadas (nf-kb) en un organismo hospedero que tenga la necesidad del mismo usando composiciones de la membrana de la cascara del huevo. - Google Patents
Metodos para el tratamiento de la desregulacion del mejorador de la cadena ligera kappa del factor nuclear de las celulas b activadas (nf-kb) en un organismo hospedero que tenga la necesidad del mismo usando composiciones de la membrana de la cascara del huevo.Info
- Publication number
- MX2017007130A MX2017007130A MX2017007130A MX2017007130A MX2017007130A MX 2017007130 A MX2017007130 A MX 2017007130A MX 2017007130 A MX2017007130 A MX 2017007130A MX 2017007130 A MX2017007130 A MX 2017007130A MX 2017007130 A MX2017007130 A MX 2017007130A
- Authority
- MX
- Mexico
- Prior art keywords
- host
- eggshell membrane
- need
- dysregulation
- enhancer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Meat, Egg Or Seafood Products (AREA)
Abstract
La presente invención se refiere al uso de composiciones de la membrana de la cáscara del huevo para activar los niveles del mejorador de la cadena ligera kappa del factor nuclear de las células B activadas ("NF-kB") en el intestino de un organismo hospedero que lo necesite y a métodos de tratamiento de las afecciones relacionadas con la desregulación de NF-kB. La presente invención proporciona un método para activar NF-kB en el intestino de un organismo hospedero que lo necesite. El método comprende administrar oralmente una cantidad eficaz de una composición que consiste esencialmente de la membrana de la cáscara del huevo, y/o materiales aislados de la membrana de la cáscara del huevo y/o materiales hidrolizados de la membrana de la cáscara del huevo, para la activación de NF-kB con respecto al organismo hospedero.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2015/054742 WO2017062016A1 (en) | 2015-10-08 | 2015-10-08 | METHODS FOR TREATING NUCLEAR FACTOR KAPPA-LIGHT-CHAIN-ENHANCER OF ACTIVATED B CELL (NF-ĸB) DYSREGULATION IN A HOST IN NEED THEREOF USING EGGSHELL MEMBRANE COMPOSITIONS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2017007130A true MX2017007130A (es) | 2018-01-30 |
Family
ID=58488181
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2017007130A MX2017007130A (es) | 2015-10-08 | 2015-10-08 | Metodos para el tratamiento de la desregulacion del mejorador de la cadena ligera kappa del factor nuclear de las celulas b activadas (nf-kb) en un organismo hospedero que tenga la necesidad del mismo usando composiciones de la membrana de la cascara del huevo. |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US10328104B2 (es) |
| EP (1) | EP3359170B1 (es) |
| JP (1) | JP2018531212A (es) |
| KR (1) | KR20180063091A (es) |
| CN (1) | CN107206029A (es) |
| AU (1) | AU2015411324B2 (es) |
| BR (1) | BR112017014304A2 (es) |
| CA (1) | CA2970101A1 (es) |
| DK (1) | DK3359170T3 (es) |
| ES (1) | ES2927890T3 (es) |
| HU (1) | HUE060219T2 (es) |
| MX (1) | MX2017007130A (es) |
| PL (1) | PL3359170T3 (es) |
| RS (1) | RS63620B1 (es) |
| RU (1) | RU2713656C2 (es) |
| WO (1) | WO2017062016A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108991521A (zh) * | 2018-08-10 | 2018-12-14 | 西北农林科技大学 | 一种肠道保护剂及其应用 |
| KR20210052064A (ko) | 2019-10-31 | 2021-05-10 | 강원대학교산학협력단 | 소나무 껍질 추출물을 유효성분으로 함유하는 허혈성 뇌혈관 질환 예방용 조성물 |
| KR102296347B1 (ko) | 2019-11-27 | 2021-09-01 | 강원대학교산학협력단 | 천연물 복합 추출물을 유효성분으로 함유하는 허혈성 뇌혈관 질환 예방용 조성물 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3194732A (en) | 1960-10-03 | 1965-07-13 | Neuhauser Irene | Assisting healing of skin-denuded areas on the body with dried non-fibrous egg-shellmembrane products and compositions therefor |
| US6410516B1 (en) | 1986-01-09 | 2002-06-25 | President & Fellows Of Harvard College | Nuclear factors associated with transcriptional regulation |
| US6617171B2 (en) * | 1998-02-27 | 2003-09-09 | The General Hospital Corporation | Methods for diagnosing and treating autoimmune disease |
| US8580315B2 (en) * | 2004-03-10 | 2013-11-12 | Esm Technologies, Llc | Anti-inflammatory activity of eggshell membrane and processed eggshell membrane preparations |
| US8324237B2 (en) * | 2005-05-20 | 2012-12-04 | Smith Charles D | Methods for the treatment and prevention of inflammatory diseases |
| US8211477B2 (en) * | 2007-10-17 | 2012-07-03 | Biova, L.L.C. | Solubilized protein composition obtained from eggshell membrane |
| US20100179103A1 (en) * | 2008-07-21 | 2010-07-15 | Ketan Desai | Curcumin cyclodextrin combination for preventing or treating various diseases |
| JP6056064B2 (ja) * | 2013-11-29 | 2017-01-11 | 国立大学法人 東京大学 | 卵殻膜成分を含むインスリン抵抗性改善剤ならびにそれを用いた組成物 |
-
2015
- 2015-10-08 DK DK15905957.5T patent/DK3359170T3/da active
- 2015-10-08 CA CA2970101A patent/CA2970101A1/en active Pending
- 2015-10-08 CN CN201580076036.0A patent/CN107206029A/zh active Pending
- 2015-10-08 RU RU2017130716A patent/RU2713656C2/ru active
- 2015-10-08 JP JP2017529084A patent/JP2018531212A/ja active Pending
- 2015-10-08 KR KR1020187008834A patent/KR20180063091A/ko unknown
- 2015-10-08 RS RS20220921A patent/RS63620B1/sr unknown
- 2015-10-08 MX MX2017007130A patent/MX2017007130A/es unknown
- 2015-10-08 ES ES15905957T patent/ES2927890T3/es active Active
- 2015-10-08 AU AU2015411324A patent/AU2015411324B2/en active Active
- 2015-10-08 US US15/528,335 patent/US10328104B2/en active Active
- 2015-10-08 EP EP15905957.5A patent/EP3359170B1/en active Active
- 2015-10-08 BR BR112017014304A patent/BR112017014304A2/pt not_active Application Discontinuation
- 2015-10-08 HU HUE15905957A patent/HUE060219T2/hu unknown
- 2015-10-08 PL PL15905957.5T patent/PL3359170T3/pl unknown
- 2015-10-08 WO PCT/US2015/054742 patent/WO2017062016A1/en active Application Filing
-
2019
- 2019-06-06 US US16/433,683 patent/US11020437B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| BR112017014304A2 (pt) | 2018-03-06 |
| AU2015411324B2 (en) | 2023-06-15 |
| EP3359170A1 (en) | 2018-08-15 |
| DK3359170T3 (da) | 2022-10-10 |
| AU2015411324A1 (en) | 2018-03-22 |
| US11020437B2 (en) | 2021-06-01 |
| RU2017130716A3 (es) | 2019-05-06 |
| EP3359170B1 (en) | 2022-09-21 |
| US20190365824A1 (en) | 2019-12-05 |
| US20180339002A1 (en) | 2018-11-29 |
| JP2018531212A (ja) | 2018-10-25 |
| US10328104B2 (en) | 2019-06-25 |
| RU2017130716A (ru) | 2019-02-28 |
| RS63620B1 (sr) | 2022-10-31 |
| WO2017062016A1 (en) | 2017-04-13 |
| EP3359170A4 (en) | 2019-05-01 |
| CN107206029A (zh) | 2017-09-26 |
| CA2970101A1 (en) | 2017-04-13 |
| ES2927890T3 (es) | 2022-11-11 |
| RU2713656C2 (ru) | 2020-02-06 |
| HUE060219T2 (hu) | 2023-02-28 |
| PL3359170T3 (pl) | 2022-11-07 |
| KR20180063091A (ko) | 2018-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12018501226A1 (en) | Methods for treating huntingtons disease | |
| MX2019015578A (es) | Metodos para tratar la enfermedad de huntington. | |
| MX337454B (es) | Composicion acuosa que contiene bromhexina. | |
| PH12015502310A1 (en) | Pharmaceutical composition, methods for treating and uses thereof | |
| MX2018000590A (es) | Moleculas de anticuerpo que se unen a agrupacion de diferenciacion 79 (cd79). | |
| ECSP10010548A (es) | Composiciones y metodos de preparacion y uso de las mismas | |
| MX2018003893A (es) | Moduladores del receptor p2x3 y p2x2/3 de diaminopirimidina para usarse en el tratamiento de la tos. | |
| MX2018004616A (es) | Cosmetica qie tiene bacterias probioticas. | |
| BR112018011622A2 (pt) | método para tratar ataque de angioedema hereditário (hae) ou reduzir a taxa de ataque de hae | |
| SG10201808055QA (en) | Compositions and methods for reducing major adverse cardiovascular events | |
| WO2016094834A3 (en) | A method for treating a complement mediated disorder caused by an infectious agent in a patient | |
| PH12017500615B1 (en) | Ophthalmic composition comprising cyclosporine and trehalose | |
| WO2018025080A3 (en) | Compositions for enhancing brain activity | |
| MX2021013354A (es) | Metodos para tratar y/o prevenir queratosis actinica. | |
| NZ602380A (en) | Peptides for vaccine against birch allergy | |
| MX2022012748A (es) | Composicion biocida y metodo. | |
| MX2017007130A (es) | Metodos para el tratamiento de la desregulacion del mejorador de la cadena ligera kappa del factor nuclear de las celulas b activadas (nf-kb) en un organismo hospedero que tenga la necesidad del mismo usando composiciones de la membrana de la cascara del huevo. | |
| WO2007079312A3 (en) | Compositions and methods for treating actin-mediated medical conditions | |
| EA201791525A3 (ru) | Соединения для лечения блокады ремиелинизации при заболеваниях, связанных с экспрессией белка оболочки herv-w | |
| MY190399A (en) | A composition comprising cistanche and ginkgo extracts, the composition useful for improving memory of a subject | |
| WO2016018799A3 (en) | Water extracts of cinnamon and radix astragali | |
| BR112015014718A2 (pt) | métodos de uso de cromatografia de troca iônica para controlar níveis de glicoformas ricas em manose | |
| AR082594A1 (es) | Docosahexanoato de pantenilo y su uso para el tratamiento y prevencion de enfermedades cardiovasculares | |
| WO2015200768A3 (en) | Pharmacologic treatments of menière's disease | |
| IN2013MU03428A (es) |